DNA Sequencing Market Insights: Unraveling Business Strategies, Growth Opportunities, and Comprehensive Industry Size | F. Hoffmann-La Roche Ltd, Macrogen, Inc., Abbott, PacBio

Market Overview:

DNA sequencing is the process of determining the order of nucleotides in DNA. It is used to study genomes and genetic variation as well as to diagnose diseases and guide treatment decisions. The market includes instruments, consumables, and software & services used for DNA sequencing applications.

Market Dynamics:

The DNA sequencing market is expected to witness significant growth over the forecast period owing to the increasing demand for personalized medicine. Personalized medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. It allows doctors or researchers to predict more accurately which treatment and prevention strategies for a particular disease will work best for each person. With advancements in DNA sequencing technologies, identification of biomarkers for various diseases has improved, allowing for more targeted disease diagnosis and treatment selection. Furthermore, reduced costs of DNA sequencing technologies are also contributing to the growing adoption of personalized medicine approaches, driving the market growth.

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/5531

DNA Sequencing Market Drivers, Restrains, Opportunities And Trends

Increasing Demand For Personalized Medicine Is Driving The Growth Of DNA Sequencing Market

The advancement in DNA sequencing technology has enabled the practice of personalized medicine which is tailored to individual patient characteristics and genomic composition. Genomic sequencing allows the identification of genetic mutations and variations associated with diseases which helps in developing targeted therapies. This is gaining popularity as it provides better treatment outcomes compare to conventional one-size-fits-all approach. As a result, more pharmaceutical companies are investing in targeted drug development which is fueling the demand for DNA sequencing.

Rising Application Of DNA Sequencing In Cancer Diagnosis And Treatment

Cancer is one of the leading causes of death worldwide. DNA sequencing has revolutionized the diagnosis and treatment of cancer. It helps in comprehensive genomic profiling of tumor to identify genetic mutations associated with specific cancer. This molecular insight enables selection of suitable targeted therapies. DNA sequencing is also used to monitor cancer progression and recurrence by detection of residual disease and mutations acquired during treatment. With growing cancer burden, implementation of DNA sequencing in clinical oncology practice is increasing considerably thereby propelling the growth of this market.

Declining Cost Of DNA Sequencing Is Restraining Market Growth

The cost of DNA sequencing has reduced dramatically over the past decade owing to technological advancements and competitive pricing by various players in the market. Earlier DNA sequencing of an entire human genome used to cost millions of dollars but now it can be done within few thousand dollars. This declining cost is making DNA sequencing affordable for clinical diagnostic purposes. However, it is also restraining the high growth rate of this market as reduced pricing fails to generate sufficient revenue. Unless new premium applications and services are introduced, price deflation can dampen the revenue and profitability of market players in long run.

Increasing Research Funding Creates Opportunities

DNA sequencing finds widespread application in biological and medical research for understanding genetic basis of diseases, drug discovery and development of diagnostics. In recent years, funding for genomic and precision medicine research from government agencies as well as private organizations has increased significantly across major markets. For example, in US, National Institute of Health (NIH) budget for human genome research rose from $476 million in 2015 to $621 million in 2021. Such rising research grants enable researchers to adopt advanced DNA sequencing techniques on large scale thereby presenting lucrative opportunities for industry players.

Whole Genome Sequencing Is Emerging As Key Trend

Earlier targeted gene panels and exome sequencing were primarily used but now whole genome sequencing (WGS) is gaining prominence. In WGS, entire genome of an individual is sequenced which provides comprehensive genomic profile. It enables detection of all types of variants including single nucleotide variants (SNVs), insertions & deletions, copy number variations, and structural variants associated with any genetic condition or disease. WGS finds wide application in prenatal testing, cancer research and personalized precision medicine. With continuous decline in sequencing cost, WGS is expected to become standard of care for clinical diagnosis and treatment in coming years. Market players are focusing on development of improved and affordable WGS solutions to capitalize on this growing trend.

List of TOP Players in Market Report are: -

◘ Thermo Fisher Scientific Inc.
◘ Illumina Inc.
◘ PerkinElmer Genomics
◘ QIAGEN
◘ Agilent Technologies Inc.
◘ F. Hoffmann-La Roche Ltd
◘ Macrogen Inc.
◘ Abbott
◘ PacBio
◘ Zymo Research Corporation
◘ Oxford Nanopore Technologies plc
◘ Tecan Trading AG
◘ Hamilton Company
◘ ZS Genetics Inc. LI-COR Inc.

𝐍𝐨𝐭𝐞: 𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐚𝐫𝐞 𝐬𝐨𝐫𝐭𝐞𝐝 𝐢𝐧 𝐧𝐨 𝐩𝐚𝐫𝐭𝐢𝐜𝐮𝐥𝐚𝐫 𝐨𝐫𝐝𝐞𝐫.

Market Detailed Segmentation:

By Product Type:

Consumables
Instruments
Services

By Technology:

Sanger Sequencing
Next-Generation Sequencing
Third- Generation DNA Sequencing
Others

By Application:

Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
Metagenomics, Epidemiology & Drug Development
Others

By End User:

Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Clinical Research
Others

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/5531

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2021
The base year for estimation - is 2021
Estimated Year - 2023
Forecast period** - 2023 to 2030

This DNA Sequencing Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the DNA Sequencing market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the DNA Sequencing market, and what are the emerging Market applications and trends?

◈ What are the projections for the global DNA Sequencing Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of DNA Sequencing , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of DNA Sequencing in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the DNA Sequencing Market?

Summarized Extracts from TOC of Market Study

Chapter 1 DNA Sequencing Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of DNA Sequencing

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the DNA Sequencing industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe DNA Sequencing Market Analysis by Countries

Chapter 9 Asia Pacific DNA Sequencing Market Analysis by Countries

Chapter 10 Middle East and Africa DNA Sequencing Market Analysis by Countries

Chapter 11 South America DNA Sequencing Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.